Imugene tweeted about Dr Bilal Shah delivering an encore presentation at the iwCAR-T 2024 meeting in Florida, on 'Updates for Allo CAR-T PBCAR0191: Bijal Shah'.
What is also interesting is that 2 members of our Scientific Advosry Board also presented at this conference. So Imugene definitely has some firepower in the CAR-T space.
Under CAR-T advances in Lung cancer:
- Tumor immune modulation in solid tumor CAR T-cell therapy: Prasad Adusumilli.
Under Genitourinary cancers.
- Advancing engineered T-cell therapies for solid tumors: Saul Priceman
GLTAH
Why IMU is a multi multi bagger, page-23189
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |